NasdaqGS - Nasdaq Real Time Price USD

AnaptysBio, Inc. (ANAB)

Compare
14.21
-0.15
(-1.04%)
At close: 4:00:02 PM EST
13.96
-0.25
(-1.76%)
After hours: 4:54:51 PM EST

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
ECOR1 CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security Purchase Jan 2, 2025 --
FAGA DANIEL R Chief Executive Officer Conversion of Exercise of derivative security Jan 6, 2025 436,466
FENTON DENNIS M Director Sale Jun 21, 2024 1,950
JAIN RITA Director Conversion of Exercise of derivative security Jun 14, 2024 4,534
LIZZUL PAUL F. Officer Conversion of Exercise of derivative security Jan 6, 2025 25,643
LOUMEAU ERIC JOSEPH Officer Conversion of Exercise of derivative security Jan 6, 2025 11,003
MULROY DENNIS MICHAEL CPA Chief Financial Officer Conversion of Exercise of derivative security Jan 6, 2025 13,802
ORWIN JOHN A Director Conversion of Exercise of derivative security Sep 13, 2024 3,335
RENTON HOLLINGS C Director Conversion of Exercise of derivative security Nov 29, 2024 1,950
SCHMID JOHN P Director Conversion of Exercise of derivative security Jun 14, 2024 3,900

Related Tickers